Angiography and interventional cardiology
There were five areas of major impact from the meeting: the use of distal projection strategies for vein graft intervention and acute myocardial infarction (AMI), new thromboatherectomy devices, the role of inflammation in percutaneous coronary intervention (PCI), new insights on drug-eluting stents...
Gespeichert in:
| Veröffentlicht in: | Journal of the American College of Cardiology 2003-07, Vol.42 (2), p.381-383 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 383 |
|---|---|
| container_issue | 2 |
| container_start_page | 381 |
| container_title | Journal of the American College of Cardiology |
| container_volume | 42 |
| creator | Zidar, James P |
| description | There were five areas of major impact from the meeting: the use of distal projection strategies for vein graft intervention and acute myocardial infarction (AMI), new thromboatherectomy devices, the role of inflammation in percutaneous coronary intervention (PCI), new insights on drug-eluting stents, and peripheral interventions. At 12 months, this benefit increased to 10.5%. [...]it appears that paclitaxel, on a polymer-based system with prolonged delivery, appears efficacious and durable. Of the high-risk entry criteria, a large percentage had restenosis after carotid endarterectomy, low ejection fraction, heart failure, >=2-vessel coronary disease, the need for open heart surgery within one month, or occlusion of the contralateral carotid. |
| doi_str_mv | 10.1016/S0735-1097(03)00674-0 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73498990</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735109703006740</els_id><sourcerecordid>3242418601</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3510-36c5103c98ed79fd8dd375516857eb854ad3b2947088320b0f00061e1c561f683</originalsourceid><addsrcrecordid>eNqFkE1LAzEQQIMotn78BKUgiD2sTjabTXKSUvyCggf1HLJJtqZsNzXZLfTfu9sWBS-e5vLmzfAQusBwiwHnd2_ACE0wCHYDZAyQsyyBAzTElPKEUMEO0fAHGaCTGBfQURyLYzTAKWeU8XSIxpN67vw8qNXnZqRqM3J1Y8Pa1o3ztapGWgXjfOXnmzN0VKoq2vP9PEUfjw_v0-dk9vr0Mp3MEk0ohoTkuhtEC24NE6XhxhBGKc45ZbbgNFOGFKnIGHBOUiig7N_CFmua4zLn5BRd77yr4L9aGxu5dFHbqlK19W2UjGSCCwEdePUHXPg2dE9HiWmnzDARvY7uKB18jMGWchXcUoWNxCD7knJbUvaZJBC5LSl7--Xe3hZLa3639uk64H4H2C7G2tkgo3a21ta4YHUjjXf_nPgG22d_1Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1506141398</pqid></control><display><type>article</type><title>Angiography and interventional cardiology</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Zidar, James P</creator><creatorcontrib>Zidar, James P</creatorcontrib><description>There were five areas of major impact from the meeting: the use of distal projection strategies for vein graft intervention and acute myocardial infarction (AMI), new thromboatherectomy devices, the role of inflammation in percutaneous coronary intervention (PCI), new insights on drug-eluting stents, and peripheral interventions. At 12 months, this benefit increased to 10.5%. [...]it appears that paclitaxel, on a polymer-based system with prolonged delivery, appears efficacious and durable. Of the high-risk entry criteria, a large percentage had restenosis after carotid endarterectomy, low ejection fraction, heart failure, >=2-vessel coronary disease, the need for open heart surgery within one month, or occlusion of the contralateral carotid.</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/S0735-1097(03)00674-0</identifier><identifier>PMID: 12875782</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Angioplasty ; Angioplasty, Balloon, Coronary - trends ; Cardiology ; Cardiology - trends ; Clopidogrel ; Combined Modality Therapy ; Coronary Angiography - trends ; Design ; Drug dosages ; Heart attacks ; Humans ; Intervention ; Ligands ; Medical imaging ; Meetings ; Mortality ; Platelet Aggregation Inhibitors - therapeutic use ; Radiation therapy ; Radiography, Interventional - trends ; Stents ; Stents - trends ; Ticlopidine - analogs & derivatives ; Ticlopidine - therapeutic use ; Treatment Outcome ; Veins & arteries</subject><ispartof>Journal of the American College of Cardiology, 2003-07, Vol.42 (2), p.381-383</ispartof><rights>2003 American College of Cardiology Foundation</rights><rights>Copyright Elsevier Limited Jul 16, 2003</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3510-36c5103c98ed79fd8dd375516857eb854ad3b2947088320b0f00061e1c561f683</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0735109703006740$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>309,310,314,776,780,785,786,3537,23911,23912,25120,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12875782$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zidar, James P</creatorcontrib><title>Angiography and interventional cardiology</title><title>Journal of the American College of Cardiology</title><addtitle>J Am Coll Cardiol</addtitle><description>There were five areas of major impact from the meeting: the use of distal projection strategies for vein graft intervention and acute myocardial infarction (AMI), new thromboatherectomy devices, the role of inflammation in percutaneous coronary intervention (PCI), new insights on drug-eluting stents, and peripheral interventions. At 12 months, this benefit increased to 10.5%. [...]it appears that paclitaxel, on a polymer-based system with prolonged delivery, appears efficacious and durable. Of the high-risk entry criteria, a large percentage had restenosis after carotid endarterectomy, low ejection fraction, heart failure, >=2-vessel coronary disease, the need for open heart surgery within one month, or occlusion of the contralateral carotid.</description><subject>Angioplasty</subject><subject>Angioplasty, Balloon, Coronary - trends</subject><subject>Cardiology</subject><subject>Cardiology - trends</subject><subject>Clopidogrel</subject><subject>Combined Modality Therapy</subject><subject>Coronary Angiography - trends</subject><subject>Design</subject><subject>Drug dosages</subject><subject>Heart attacks</subject><subject>Humans</subject><subject>Intervention</subject><subject>Ligands</subject><subject>Medical imaging</subject><subject>Meetings</subject><subject>Mortality</subject><subject>Platelet Aggregation Inhibitors - therapeutic use</subject><subject>Radiation therapy</subject><subject>Radiography, Interventional - trends</subject><subject>Stents</subject><subject>Stents - trends</subject><subject>Ticlopidine - analogs & derivatives</subject><subject>Ticlopidine - therapeutic use</subject><subject>Treatment Outcome</subject><subject>Veins & arteries</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1LAzEQQIMotn78BKUgiD2sTjabTXKSUvyCggf1HLJJtqZsNzXZLfTfu9sWBS-e5vLmzfAQusBwiwHnd2_ACE0wCHYDZAyQsyyBAzTElPKEUMEO0fAHGaCTGBfQURyLYzTAKWeU8XSIxpN67vw8qNXnZqRqM3J1Y8Pa1o3ztapGWgXjfOXnmzN0VKoq2vP9PEUfjw_v0-dk9vr0Mp3MEk0ohoTkuhtEC24NE6XhxhBGKc45ZbbgNFOGFKnIGHBOUiig7N_CFmua4zLn5BRd77yr4L9aGxu5dFHbqlK19W2UjGSCCwEdePUHXPg2dE9HiWmnzDARvY7uKB18jMGWchXcUoWNxCD7knJbUvaZJBC5LSl7--Xe3hZLa3639uk64H4H2C7G2tkgo3a21ta4YHUjjXf_nPgG22d_1Q</recordid><startdate>20030716</startdate><enddate>20030716</enddate><creator>Zidar, James P</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20030716</creationdate><title>Angiography and interventional cardiology</title><author>Zidar, James P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3510-36c5103c98ed79fd8dd375516857eb854ad3b2947088320b0f00061e1c561f683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Angioplasty</topic><topic>Angioplasty, Balloon, Coronary - trends</topic><topic>Cardiology</topic><topic>Cardiology - trends</topic><topic>Clopidogrel</topic><topic>Combined Modality Therapy</topic><topic>Coronary Angiography - trends</topic><topic>Design</topic><topic>Drug dosages</topic><topic>Heart attacks</topic><topic>Humans</topic><topic>Intervention</topic><topic>Ligands</topic><topic>Medical imaging</topic><topic>Meetings</topic><topic>Mortality</topic><topic>Platelet Aggregation Inhibitors - therapeutic use</topic><topic>Radiation therapy</topic><topic>Radiography, Interventional - trends</topic><topic>Stents</topic><topic>Stents - trends</topic><topic>Ticlopidine - analogs & derivatives</topic><topic>Ticlopidine - therapeutic use</topic><topic>Treatment Outcome</topic><topic>Veins & arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zidar, James P</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zidar, James P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Angiography and interventional cardiology</atitle><jtitle>Journal of the American College of Cardiology</jtitle><addtitle>J Am Coll Cardiol</addtitle><date>2003-07-16</date><risdate>2003</risdate><volume>42</volume><issue>2</issue><spage>381</spage><epage>383</epage><pages>381-383</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>There were five areas of major impact from the meeting: the use of distal projection strategies for vein graft intervention and acute myocardial infarction (AMI), new thromboatherectomy devices, the role of inflammation in percutaneous coronary intervention (PCI), new insights on drug-eluting stents, and peripheral interventions. At 12 months, this benefit increased to 10.5%. [...]it appears that paclitaxel, on a polymer-based system with prolonged delivery, appears efficacious and durable. Of the high-risk entry criteria, a large percentage had restenosis after carotid endarterectomy, low ejection fraction, heart failure, >=2-vessel coronary disease, the need for open heart surgery within one month, or occlusion of the contralateral carotid.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>12875782</pmid><doi>10.1016/S0735-1097(03)00674-0</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0735-1097 |
| ispartof | Journal of the American College of Cardiology, 2003-07, Vol.42 (2), p.381-383 |
| issn | 0735-1097 1558-3597 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_73498990 |
| source | MEDLINE; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Angioplasty Angioplasty, Balloon, Coronary - trends Cardiology Cardiology - trends Clopidogrel Combined Modality Therapy Coronary Angiography - trends Design Drug dosages Heart attacks Humans Intervention Ligands Medical imaging Meetings Mortality Platelet Aggregation Inhibitors - therapeutic use Radiation therapy Radiography, Interventional - trends Stents Stents - trends Ticlopidine - analogs & derivatives Ticlopidine - therapeutic use Treatment Outcome Veins & arteries |
| title | Angiography and interventional cardiology |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T22%3A54%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Angiography%20and%20interventional%20cardiology&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Zidar,%20James%20P&rft.date=2003-07-16&rft.volume=42&rft.issue=2&rft.spage=381&rft.epage=383&rft.pages=381-383&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/S0735-1097(03)00674-0&rft_dat=%3Cproquest_cross%3E3242418601%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1506141398&rft_id=info:pmid/12875782&rft_els_id=S0735109703006740&rfr_iscdi=true |